Felbamate (Alvogen Inc.)
Welcome to the PulseAid listing for the Felbamate drug offered from Alvogen Inc.. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Alvogen Inc. |
| NON-PROPRIETARY NAME: | felbamate |
| SUBSTANCE NAME: | FELBAMATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-12-28 |
| END MARKETING DATE: | 0000-00-00 |
Felbamate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Felbamate from Alvogen Inc. |
| LABELER NAME: | Alvogen Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 400(mg/1) |
| START MARKETING DATE: | 2016-12-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 47781-550_eddcc497-d6d9-d5a7-5508-df4ec6c39072 |
| PRODUCT NDC: | 47781-550 |
| APPLICATION NUMBER: | ANDA204595 |
Other FELBAMATE Pharmaceutical Manufacturers / Labelers:
